IsoRay, Inc. (ISR) Awarded More Than $526,000 in Federal Grants for Breast, Brain and Lung Cancer
11/8/2010 10:12:50 AM
RICHLAND, Wash.--(BUSINESS WIRE)--IsoRay, Inc. (Amex: ISR) announced, today, it has been awarded $526,910 under the IRS Qualifying Therapeutic Discovery Program (QTDP). Created by Congress, the program is part of the Patient Protection and Affordable Care Act of 2010. The QTDP provides financial support for innovative projects that the U.S. Department of Health and Human Services believes could well result in a new therapy, reduce health care costs, or represent an important advance in finding a cure for cancer.